Morgan Stanley’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Hold
0
-$23 8351
2025
Q3
Hold
0
8027
2025
Q2
Hold
0
7962
2025
Q1
Hold
0
7731
2024
Q4
Hold
0
7395
2024
Q3
Hold
0
7341
2024
Q2
Hold
0
7166
2024
Q1
Sell
-2
Closed -$8.75K 7336
2023
Q4
$14K Buy
2
+1
+100% +$13.7K ﹤0.01% 6757
2023
Q3
$12.8K Hold
1
﹤0.01% 6645
2023
Q2
$28.9K Hold
1
﹤0.01% 6431
2023
Q1
$26.8K Buy
+1
New +$166K ﹤0.01% 6521
2022
Q4
Hold
0
6670
2022
Q3
Hold
0
6857
2022
Q2
Hold
0
6962
2022
Q1
Hold
0
6195
2021
Q4
Hold
0
6750
2021
Q3
Hold
0
6498
2021
Q2
Hold
0
6379
2021
Q1
Hold
0
5783
2018
Q2
Hold
0
6702
2018
Q1
Hold
0
6650
2017
Q4
Hold
0
6602
2017
Q3
Hold
0
6563
2017
Q2
Hold
0
6615
2017
Q1
Hold
0
6588
2016
Q3
Hold
0
-$2K 6531
2016
Q2
Hold
0
6364
2016
Q1
Hold
0
6398
2015
Q4
Hold
0
6726
2015
Q3
Hold
0
6662
2015
Q2
Hold
0
6694

Other funds holding JAGX

Morgan Stanley's JAGX Position: Q4 2025 in Review

Morgan Stanley held its Jaguar Health (JAGX) position steady in Q4 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8351.

Morgan Stanley first reported a position in JAGX in Q1 2023 and has held it in 4 quarters since. The position peaked at $28.9K in Q2 2023. 10 funds tracked by Wall St. Rank hold JAGX as of Q4 2025.

  • Morgan Stanley held 0 shares of Jaguar Health worth $0 as of Q4 2025.
  • Morgan Stanley left its Jaguar Health share count unchanged in Q4 2025.
  • Jaguar Health made up ﹤0.01% of Morgan Stanley's portfolio in Q4 2025, its #8351 holding.
  • Morgan Stanley first reported a position in Jaguar Health in Q1 2023 and has held it in 4 quarters since.
  • Morgan Stanley's Jaguar Health position peaked at $28.9K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Jaguar Health as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.